PW6-55672-96928
4 vaccinations
3 coded responses
52 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 983 / WA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 1 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-12
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-05-04
Dose 2 — Pfizer-BioNTech
- 2021-05-04
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-20
- 2021-05-27
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-08-03
- 2021-11-02
-
2021-11-09
Dose 3 — Moderna
-
2021-11-09
Survey response — day 0, dose 3MedDRA: Oropharyngeal pain — Feeling: Good · Headache, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-16
- 2021-11-23
- 2021-12-02
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2022-02-08
- 2022-05-10
-
2022-11-09
Survey response — 12 months, dose 3MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Pregnancy and CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-11-10
-
2022-12-20
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-12-20
-
2022-12-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
-
2022-12-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-12-23
- 2022-12-24
- 2022-12-25
- 2022-12-26
- 2022-12-27
- 2023-01-03
- 2023-01-10
-
2023-01-17
Survey response — day 28, dose 4MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-01-24
- 2023-01-31
- 2023-03-21
- 2023-06-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | |
| 2 | 2021-05-04 | Pfizer-BioNTech | |
| 3 | 2021-11-09 | Moderna | No |
| 4 | 2022-12-20 | Pfizer-BioNTech | Tetanus |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): Sore throat
Release 12 — 12 months, dose 3
Symptoms: Pregnancy and Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release